A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

Name: A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
License: Public Domain

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

urinary bladder cancer, invasive bladder cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 398310
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.